Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo.

Zhang Y, Beck CA, Poletti A, Clement JP 4th, Prendergast P, Yip TT, Hutchens TW, Edwards DP, Weigel NL.

Mol Endocrinol. 1997 Jun;11(6):823-32.

PMID:
9171245
2.

Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites.

Knotts TA, Orkiszewski RS, Cook RG, Edwards DP, Weigel NL.

J Biol Chem. 2001 Mar 16;276(11):8475-83. Epub 2000 Dec 7.

3.
4.

pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.

Panigone S, Debernardi S, Taya Y, Fontanella E, Airoldi R, Delia D.

Oncogene. 2000 Aug 17;19(35):4035-41.

5.

Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4.

Leng X, Noble M, Adams PD, Qin J, Harper JW.

Mol Cell Biol. 2002 Apr;22(7):2242-54.

6.
7.

The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.

Luciani MG, Hutchins JR, Zheleva D, Hupp TR.

J Mol Biol. 2000 Jul 14;300(3):503-18.

PMID:
10884347
8.

HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.

Hall C, Nelson DM, Ye X, Baker K, DeCaprio JA, Seeholzer S, Lipinski M, Adams PD.

Mol Cell Biol. 2001 Mar;21(5):1854-65.

9.

Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.

Garrett S, Barton WA, Knights R, Jin P, Morgan DO, Fisher RP.

Mol Cell Biol. 2001 Jan;21(1):88-99.

10.

The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine.

Kaldis P, Cheng A, Solomon MJ.

J Biol Chem. 2000 Oct 20;275(42):32578-84.

12.

Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro.

Higashi H, Suzuki-Takahashi I, Taya Y, Segawa K, Nishimura S, Kitagawa M.

Biochem Biophys Res Commun. 1995 Nov 13;216(2):520-5.

PMID:
7488142
13.

Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases.

Zarkowska T, Mittnacht S.

J Biol Chem. 1997 May 9;272(19):12738-46.

14.

Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor.

Zhang Y, Beck CA, Poletti A, Edwards DP, Weigel NL.

Mol Endocrinol. 1995 Aug;9(8):1029-40.

PMID:
7476977
16.

Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2.

Yam CH, Siu WY, Lau A, Poon RY.

J Biol Chem. 2000 Feb 4;275(5):3158-67.

17.
18.

Phosphorylation of E2F-1 by cyclin A-cdk2.

Kitagawa M, Higashi H, Suzuki-Takahashi I, Segawa K, Hanks SK, Taya Y, Nishimura S, Okuyama A.

Oncogene. 1995 Jan 19;10(2):229-36.

PMID:
7838523
19.

Use of an oriented peptide library to determine the optimal substrates of protein kinases.

Songyang Z, Blechner S, Hoagland N, Hoekstra MF, Piwnica-Worms H, Cantley LC.

Curr Biol. 1994 Nov 1;4(11):973-82.

PMID:
7874496
20.

Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47D.

Deguchi H, Fujii T, Nakagawa S, Koga T, Shirouzu K.

Int J Oncol. 2002 Dec;21(6):1301-5.

PMID:
12429981

Supplemental Content

Support Center